Manufacturer copay assistance · Briumvi (J2329) · TG Therapeutics
Eligible patients pay $0… · Maximum benefit Up to $20,000/year. Plus infusion administration support: $550 first infusion, $350 per infusion thereafter. · Covers Briumvi drug copay only — does NOT cover infusion administration
Published terms from the manufacturer. Per-patient eligibility is confirmed at enrollment.
This manufacturer program excludes government insurance. Foundation disease funds are the route instead — status shown as of each fund's last verification.
Run a benefits estimate for Briumvi — the program's cap applies against the patient share CareCost calculates.
Yes — BRIUMVI Co-pay Assistance Program from TG Therapeutics. Eligible patients pay $0 (or low fixed cost — see notes). Commercial insurance is required; Medicare and Medicaid patients are not eligible.
Eligible patients pay $0 (or low fixed cost — see notes) Maximum benefit: Up to $20,000/year. Plus infusion administration support: $550 first infusion, $350 per infusion thereafter.. Covers Briumvi drug copay only — does NOT cover infusion administration
Accepted insurance: commercial. Not eligible: medicare, medicaid, tricare, va, government.